Related Experiment Videos
Tranexamic acid (Cyklokapron) in chronic urticaria: a double-blind study
Acta Dermato-Venereologica
|January 1, 1977
Summary
Tranexamic acid did not significantly improve chronic urticaria symptoms in patients with low C1-esterase inhibitor levels. The double-blind study found no difference compared to placebo treatment.
Area of Science:
- Dermatology
- Immunology
- Allergy
Background:
- Chronic urticaria is a common dermatological condition.
- Some patients with chronic urticaria exhibit reduced levels of C1-esterase inhibitor.
- C1-esterase inhibitor plays a role in regulating inflammatory pathways.
Purpose of the Study:
- To investigate the efficacy of tranexamic acid in treating chronic urticaria.
- To assess the impact of tranexamic acid on patients with depressed C1-esterase inhibitor levels.
Main Methods:
- A double-blind, placebo-controlled study was conducted.
- 17 patients diagnosed with chronic urticaria participated.
- Patients received either tranexamic acid (Cyklokapron) or a placebo.
Main Results:
- No statistically significant difference in symptom improvement was observed between the tranexamic acid and placebo groups.
- The treatment periods showed comparable outcomes for both interventions.
Conclusions:
- Tranexamic acid does not appear to be an effective treatment for chronic urticaria in patients with slightly depressed C1-esterase inhibitor values.
- Further research may be needed to explore alternative therapeutic strategies for this patient subgroup.